With the single-day spike in COVID-19 cases setting records, India’s second wave is feared to be longer and more intense than the first one.
COVID-19 in the last one year has once again reminded us of the growing inequalities in India. A recent Pew Research Report shows that India’s middle class may have shrunk
Every year on March 21, a global movement gathers to fight prejudice and intolerance by marking the International Day for the Elimination of Racial Discrimination.
The optimism that India might have beaten the COVID-19 pandemic has given way to pessimism from a sharp increase in new cases and deaths from the disease.
A novel virus SARS-CoV-2 overtook an ancient bacteria, tuberculosis or TB, as the leading infectious cause of death.
The launch of Brazil’s Amazonia-1 satellite by the Indian Space Research Organisation (ISRO) comes weeks after India allowed the export of COVID-19 vaccine to Brazil, as part of its “vaccine maitri” diplomacy.
The Centre, in a first move of its kind, has issued Rs 5,500 crore in zero-coupon bonds for recapitalising Punjab and Sind Bank (P&SB) and allowed it to park the paper in its held-to-maturity (HTM) category at face value rather than the discounted market rate.
With the advent of 2021, the Indian regulators deliberate over approving the use of Covishield, Serum Institute of India’s version of the AstraZeneca-Oxford vaccine there is a sense of optimism in the public, investors and market participants.
The approval of Drug regulator to Cadila Healthcare Ltd to conduct Phase 3 clinical trials of its ZyCoV-D vaccine candidate for Covid-19.
Despite Covid-19 restrictions and the risk of animal to human disease transmission, illegal wildlife trade on social media networks has continued, with wild animals sometimes sold as “lockdown pets”.